« Back to Record
Citation APA

Classe, J. M., Meeus, P., Hudry, D., Wernert, R., Quenet, F., Marchal, F., Houvenaeghel, G., Bats, A. S., Lécuru, F., Ferron, G., Brigand, C., Berton, D., Gladieff, L., Joly, F., Ray-Coquard, I., Durand-Fontanier, S., Liberale, G., Pocard, M., Georgeac, C., Gouy, S., Guilloit, J. M., Guyon, F., Costan, C., Rousselet, J. M., de Guerké, L., Bakrin, N., Brument, E., Martin, E., Asselain, B., Campion, L., & Glehen, O. (2024). Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial. Lancet oncology, 25(12), 1551-1562. doi:10.1016/S1470-2045(24)00531-X


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/387460

Classe, J. M., Meeus, P., Hudry, D., Wernert, R., Quenet, F., Marchal, F., Houvenaeghel, G., Bats, A. S., Lécuru, F., Ferron, G., Brigand, C., Berton, D., Gladieff, L., Joly, F., Ray-Coquard, I., Durand-Fontanier, S., Liberale, G., Pocard, M., Georgeac, C., Gouy, S., Guilloit, J. M., Guyon, F., Costan, C., Rousselet, J. M., de Guerké, L., Bakrin, N., Brument, E., Martin, E., Asselain, B., Campion, L., & Glehen, O. (2024). Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial. Lancet oncology, 25(12), 1551-1562. doi:10.1016/S1470-2045(24)00531-X